New meningitis B vaccines - does the best science matter? Published 20th November 2009
At the recent Meningitis Research Foundation (MRF) meeting in London (12th & 13th November 2009), new vaccines to protect against N.meningitidis serogroup B were discussed. Both Wyeth and Novartis Vaccines are positioning their approaches on the best science. VacZine Analytics discuss the current issues.
PREMIUMThis article is available only on a "pay per view" basis or to purchasers of MarketVIEW: Meningitis ACWY vaccines (CAT No; VAMV009), published December 2009.